Jeffrey S. Ervin

CIK: 0001762163

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ALLR

Allarity Therapeutics, Inc.

Officer

CING

Cingulate Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ALLR
Allarity Therapeutics, Inc.
Jan 28, 2026
Award(A)
Direct
150K shares-
CING
Cingulate Inc.
Jun 20, 2025
Award(A)
Stock Option (right to Buy)
Direct
15K shares-

		Type	Shares	Price		Ownership
Jan 28, 2026	ALLR Allarity Therapeutics, Inc.	Award(A)	150,000	-	$0	Direct
Jun 20, 2025	CING Cingulate Inc.	Award(A) Stock Option (right to Buy)	15,000	-	-	Direct

1-2 of 2 transactions

About Ervin Jeffrey S

Ervin Jeffrey S (SEC CIK 0001762163) files insider reports with the SEC as CFO of Allarity Therapeutics, Inc. (ALLR) and Director of Cingulate Inc. (CING).

Signal8 holds 3 ownership filings by Ervin Jeffrey S (1 Form 3, 2 Form 4), filed between Jun 23, 2025 and Apr 30, 2026. Those filings report 2 transactions, from Jun 20, 2025 to Jan 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ervin Jeffrey S's filings is in TARPON SPRINGS, FL.

Recent filings by Ervin Jeffrey S

Jan 28, 2026: Grant or award of ALLR shares (Form 4, code A).
Jun 20, 2025: Grant or award of CING derivative securities (Form 4, code A).

Other insiders filing for Allarity Therapeutics, Inc. (ALLR)

How to read Form 4 transaction codes